Alaunos Therapeutics (TCRT) Gains from Investment Securities (2009 - 2025)
Alaunos Therapeutics (TCRT) reported Gains from Investment Securities of $31000.0 for Q2 2025, up 520.0% quarter-over-quarter from $5000.0 in Q4 2023.
Alaunos Therapeutics (TCRT) Gains from Investment Securities (2009 - 2025) Analysis & Trends
Alaunos Therapeutics has reported Gains from Investment Securities for 16 years, with the latest figure at $31000.0 in Q2 2025.
- For the quarter ending Q2 2025, Gains from Investment Securities changed N/A year-over-year to $31000.0; the trailing twelve-month figure through Dec 2025 stood at $31000.0 (up 933.33% YoY), and the FY2025 full-year result was $31000.0, changed N/A from the prior year.
- Gains from Investment Securities for Q2 2025 stood at $31000.0, up from $5000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $508000.0 in Q4 2021, with the low at -$559000.0 in Q1 2021.
- Historically, Gains from Investment Securities has averaged $1545.5 across 4 years, with a median of -$2000.0 in 2023.
- The largest YoY upside for Gains from Investment Securities was 50900.0% in 2021 against a maximum downside of 850.0% in 2021.
- Alaunos Therapeutics' Gains from Investment Securities stood at $508000.0 in 2021, then plunged by 101.38% to -$7000.0 in 2022, then surged by 171.43% to $5000.0 in 2023, then jumped by 520.0% to $31000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $31000.0 (Q2 2025), $5000.0 (Q4 2023), and -$2000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Dec 31, 2021 | 508,000.00 |
| Dec 31, 2021 | 508,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | 66,000.00 |
| Jun 30, 2021 | 66,000.00 |